Longview residents were out in front of the Gregg County Courthouse on Saturday to take part in the Walk to End Alzheimer’s ...

Frontotemporal dementia can be hard to diagnose because while dementia can be part of the illness, it's not a factor in all ...

Sage Therapeutics has said it will stop the development of dalzanemdor in Alzheimer's disease, a few months after pulling the ...

The brain has a waste-disposal system that clears away junk proteins that contribute to the development of dementia an ...

Researchers at Indiana University School of Medicine are examining the brains of individuals with asymptomatic Alzheimer's ...

Sage Therapeutics does not plan further clinical development of its dalzanemdor drug candidate in Alzheimer's disease following its failure in a mid-stage study.

(RTTNews) - Sage Therapeutics, Inc. (SAGE) Tuesday said its Phase 2 LIGHTWAVE study to evaluate dalzanemdor in participants with mild cognitive impairment (MCI) or mild dementia due to Alzheimer's ...

On Sunday was the walk to end Alzheimer’s event at the Meadowbrook mall. Where people can walk or donate money to help with ...

Researchers show that a pill form of the drug dronabinol, an FDA-approved synthetic version of marijuana's main ingredient, THC, reduces agitation in patients with Alzheimer's by an average of 30%.

AG03, targets two key areas of the Tau protein in Alzheimer's disease, showing effectiveness in lab and fruit fly models.

Nearly seven million Americans are living with Alzheimer’s disease – a leading cause of death in the United States.

When the annual Walk to End Alzheimer’s began in Teague Park, Dan Keefe — a resident of Arabella of Longview Senior Living — ...